Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2006-01-24
2010-10-26
Badio, Barbara P (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C552S646000, C552S647000
Reexamination Certificate
active
07820642
ABSTRACT:
Disclosed are compounds of the formula (I)wherein R is C1-C30alkyl, which may be optionally further substituted with one or more of C5-C8cycloalkyl groups, or a C5-C12cycloalkyl, which may be optionally substituted with one or more C1-C30alkyl groups, R′ is hydrogen or lower alkyl, R″ is a C1-C30alkyl or halo, and the bond between C14 and C15 can be a single bond or double bond. Also disclosed are pharmaceutical compositions comprising such compounds and methods of use thereof. These compounds can find use in treating a number of diseases or conditions such as hypogonadism, osteoporosis, and anemia, in providing hormonal therapy and contraception, as an anabolic agent, and in suppressing the release of hormones such as the luteinizing hormone.
REFERENCES:
patent: 3056727 (1961-10-01), Allais et al.
patent: 3314856 (1967-04-01), Allais et al.
patent: 3515720 (1970-06-01), Scribner
patent: 3523126 (1970-08-01), Boswell
patent: 3629244 (1971-12-01), Costerousse
patent: 3637771 (1972-01-01), Nedelec et al.
patent: 3862195 (1975-01-01), Gastaud
patent: 5952319 (1999-09-01), Cook et al.
patent: 6369047 (2002-04-01), Cook et al.
patent: 6670352 (2003-12-01), Cook et al.
patent: 2002/0002156 (2002-01-01), Cook et al.
patent: 2002/0103177 (2002-08-01), Cook et al.
patent: 2003/0069215 (2003-04-01), Blye et al.
patent: 2003/0130243 (2003-07-01), Blye et al.
patent: 1291293 (1970-05-01), None
patent: WO 01/74839 (2001-10-01), None
Muddana et al., “11beta-alkyl-Delta9-19-nortestosterone derivatives: high-affinity ligands and potent partial agonists of the androgen receptor,”J. Med. Chem., 47, 4985-4988 (2004).
Blye Richard P.
Kim Hyun K.
Badio Barbara P
Leydig , Voit & Mayer, Ltd.
The United States of America as represented by the Department of
LandOfFree
Nandrolone 17β-carbonates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nandrolone 17β-carbonates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nandrolone 17β-carbonates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4167654